Lataa...
Refractory adult-onset Still disease treated by tocilizumab combined with methotrexate: A STROBE-compliant article
Some patients have poor response to adult-onset Still disease (AOSD) traditional treatment, which easily recurs during the reduction of prednisone. We observed the efficacy and safety of tocilizumab combined with methotrexate (MTX) in the treatment of refractory AOSD, and to explore the possibility...
Tallennettuna:
| Julkaisussa: | Medicine (Baltimore) |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wolters Kluwer Health
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6708626/ https://ncbi.nlm.nih.gov/pubmed/31393368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016682 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|